Back to Results
First PageMeta Content
Microbiology / Ceftazidime / Thiazoles / Zwitterions / Klebsiella pneumoniae / Pseudomonas aeruginosa / Proteus / Beta-lactamase / Bacteria / Enterobacteria / Gram-negative bacteria


Introductory Remarks: Overview of NDA[removed]Ceftazidime-Avibactam Sumati Nambiar, MD MPH Director, Division of Anti-Infective Products FDA
Add to Reading List

Open Document

File Size: 1,58 MB

Share Result on Facebook

Company

Cerexa Inc. / Actavis plc / /

IndustryTerm

drug product / /

MedicalCondition

Pseudomonas / pneumonia / bacteremia / Aerobic Gram-negative infections / disease / Skin infections / infectious diseases / infection / urinary tract infections / concurrent bacteremia / intra-abdominal infections / polymicrobial infections / nervous system infections / skin structure infections Urinary tract infections / acute pyelonephritis / /

MedicalTreatment

alternative therapies / /

Organization

Anti-Infective Products FDA Anti-Infective Drugs Advisory Committee / /

Position

MPH Director / Division / /

Product

Ceftazidime / metronidazole / /

Technology

AVI / /

URL

http /

SocialTag